Spelling suggestions: "subject:"pyogenes"" "subject:"dyogenes""
21 |
Zur pathogenität des Bacillus pyogenes suis ...Gerhard, Karl, January 1904 (has links)
Inaug.-Diss.--Giessen. / Lebenslauf.
|
22 |
SiaA, a heme proteinLibkind, Marianna. January 2006 (has links)
Thesis (honors)--Georgia State University, 2006. / Title from title screen. Under the direction of Dabney White Dixon. Electronic text (46 p. : ill. (some col.)) : digital, PDF file. Description based on contents viewed Aug. 1, 2007. Includes bibliographical references (p 45-46).
|
23 |
The SCL1 protein of Streptococcus pyogenes a structure-function analysis /Caswell, Clayton Christopher. January 2008 (has links)
Thesis (Ph. D.)--West Virginia University, 2008. / Title from document title page. Document formatted into pages; contains xi, 190 p. : ill. (some col.). Includes abstract. Includes bibliographical references.
|
24 |
Induction of myosin cross-reactive antibody and cytolytic T cell responses in mice with Streptococcus pyogenesCunningham, Cynthia A. January 2000 (has links)
Thesis (Ph. D.)--West Virginia University, 2000. / Title from document title page. Document formatted into pages; contains x, 185 p. : ill. Includes abstract. Includes bibliographical references.
|
25 |
Cellular Mechanisms of Neurovascular Breakdown and Neuronal Dysfunction Following Recurrent Group A Streptococcus Infections in MicePlatt, Maryann P. January 2019 (has links)
Autoimmune encephalitic (AE) syndromes represent a unique manifestation of autoimmunity: the immune system recognizes the brain as foreign, and interferes with neuronal function. AE syndromes are characterized by hallucinations, paranoia, anxiety, seizures, and autonomic dysregulation, and progress over a matter of weeks as autoantibodies targeting the brain bind more densely to their CNS targets. Development of AE has been linked to peripheral tumors and infection, both of which provide structural mimetics to CNS antigens to incite an immune response in the periphery. How these brain-specific antibodies reach the CNS remains unclear.
In rare cases, Group A Streptococcus (GAS, S. pyogenes) infections can cause CNS autoimmunity targeting the basal ganglia, termed post-infectious basal ganglia encephalitis (BGE), manifesting as motor (Sydenham’s chorea) and psychiatric (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus, PANDAS) abnormalities. In a mouse model of post-infectious BGE, we have shown that repeated intranasal GAS infections generate robust T cell infiltration into the CNS, concomitant with blood-brain barrier breakdown, microglial activation, and olfactory synapse degradation. However, the different T cell subtypes that enter the brain, how they enter the CNS, and their relative contributions to neural dysfunction and neuroinflammation remain unclear.
Th17 lymphocytes are heavily implicated in many autoimmune diseases, but whether the inflammatory post-infectious BGE reaction induces functional deficits in odor processing and requires Th17 lymphocytes was unknown. Here we demonstrate that mice lacking Th17 lymphocytes display both reduced BBB impairment and antibody infiltration. Furthermore, multiple GAS infections induce deficits in odor processing, which are partially ameliorated in Th17 cell-deficient mice. Notably, neuroinflammation and some excitatory synaptic loss persist, due to the presence of Th1 lymphocytes. Th17 lymphocytes are therefore critical for both selective CNS entry of autoantibodies and neural circuit impairment during post-infectious BGE. By examining the regulation of chemokine ligand expression in GAS-inoculated mice, we determined that CCL20/CCR6 and CCL2/CCR2 chemokine axes are implicated in T cell homing to the brain. In chemokine receptor mutant CCR6+/- CCR2-/- mice, T cell infiltration is reduced by 86.2%, and microglial activation is blunted. These findings suggest that CCL2/CCR2 and CCL20/CCR6 signaling may play a role in T cell homing to the brain and neuroinflammation. Finally, we first assessed behavioral and immune responses in two different GAS exposure models. It was clear that while behavioral abnormalities can be recapitulated in mice given subcutaneous GAS immunizations, this elicited relatively weak cellular and humoral immune responses. By contrast, mice given intranasal GAS inoculations showed minimal behavioral abnormalities, but elicited robust humoral and cellular immune responses.
Taken together, these data demonstrate the pivotal role of Th17 lymphocytes in brain pathology and olfactory processing deficits after recurrent GAS infections in our mouse model. Our intranasal inoculation model supports the conclusion that post-infectious BGE is autoimmune in nature, despite the absence of behavioral symptoms in this model. Using multiple mouse models of post-infectious BGE may allow us to study distinct facets of disease pathogenesis. Finally, this work underscores the ability of T cells to incite neuroinflammation, provides a useful clinical diagnostic test in olfactory functional assessments, and lends support to T cell immunotherapy strategies in patients with post-infectious BGEs.
|
26 |
The rpsL gene and streptomycin resistance in Streptococcus gordonii and Streptococcus pyogenesVidyasanker, Radhika 13 December 1999 (has links)
Streptomycin resistance in both gram-positive and gram-negative
bacteria is usually caused by a single mutation in
the rpsL gene. The rpsL gene encodes the S12 protein of
the ribosomal complex. The rpsL genes of various bacteria
have consensus regions in their sequences. Primers were
designed from these consensus pockets and a fragment of the
rpsL gene was sequenced from S. gordonii using PCR based
methodologies. Using the Multiplex Restriction Sequence
PCR(mRS PCR), which used the known primer at one end and a
restriction site primer on the other, a gene walk was
conducted. In streptomycin resistant strains of S.
gordonii, namely GP204, SP204 and SP635, the AAA coding for
Lys56 was mutated to ACA, coding for Thr56. The lysine to
threonine transition, causing resistance to streptomycin
was identical to that expected from the literature.
The streptomycin resistance gene of S. pyogenes was
mapped using similar techniques. Streptomycin resistant
strains S43 ATCC, 543/192/4 and S43/192/30R were studied.
In streptomycin resistant S43 ATCC and S43/192/30R strains,
the lysine 56 changed to isoleucine and threonine
respectively. Surprisingly, the 192/4 had two mutations,
in each of the two hotspots in the rpsL gene where
mutations due to streptomycin resistance occur. It had the
amino acid 56, lysine, mutated to arginine and lysine 101
changed to asparagine. To check if this mutation was
stable in the host animal, S43/192/4 P8 (S43/192/4 passaged
eight times in mice) was sequenced and the sequence was
identical to the streptomycin resistant 192/4. Hence, the
lys101 mutation was stable and unlike the ancillary
mutations in E.coli and S. typhimurium, which are
compensated by new mutations.
The pathogenesis of S. pyogenes depends in part on the
ability of the pathogen to adhere to the epithelial cells
of the throat and the quantity of M protein. Pathogenesis
studies done on mice revealed the avirulence of S43/192/4smR
strain. To elucidate the reason for this avirulence, the
adherence properties and the production of M protein of the two strains S43/192/4smR and S43/192/30R were tested.
Qualitative immunoblot analysis of the M protein of 192/4
and 30R revealed no significant difference. Competition
ELISA was conducted to quantitate the M protein, and this
also did not show any significant difference in the M
protein levels. The adherence of 30R and 192/4 was measured
on human pharyngeal epithelial cell line. The adherence
properties of S43/192/4 SmR, was no different from other
strains in this experiment. Electron microscopy, using
immunogold to highlight the M protein on the cell surface
showed no differences. / Graduation date: 2000
|
27 |
Genetics of type 5 M protein of Streptococcus pyogenesKehoe, M.A., Miller, L., Poirier, T.P., Beachey, E.H., Lee, M., Harrington, Dean J. January 1987 (has links)
No
|
28 |
Estudi epidemiològic d'infeccions invasives i no invasives produïdes per Streptococcus pyogenesRivera Martínez, M. Alba 06 June 2008 (has links)
Streptococcus pyogenes és un patogen humà responsable d'un ampli ventall d'infeccions que varien des d'infeccions superficials com faringitis i impetigen a formes sistèmiques greus com fascitis necrosant (FN) i síndrome del xoc tòxic estreptocòccic (SSTS). El ressorgiment i persistència de formes invasives greus descrit des de mitjans dels anys 1980 ha motivat una intensa recerca sobre els aspectes epidemiològics, microbiològics i clínics d'aquestes infeccions. S'ha realitzat un estudi retrospectiu de base hospitalària que inclou 126 soques de S. pyogenes (27 procedents d'infeccions invasives i 99 d'infeccions no invasives) aïllades entre gener de 1999 i juny de 2003. Les soques de S. pyogenes es van caracteritzar en base a la distribució de tipus i subtipus emm i els perfils genètics de superantígens (SAgs) (speA-C, speF-J, speL, speM, ssa i smeZ). Tanmateix, es va determinar la prevalença i els mecanismes de resistència a macròlids, tetraciclina i levofloxacino. Les formes clíniques més freqüents d'infecció invasiva van ser les infeccions de la pell i teixits tous (40,7%). La SSTS es va registrar en quatre (14,8%) dels casos invasius i es va associar a FN en la meitat dels casos. La majoria dels pacients afectats de quadres invasius eren adults, en particular d'edat avançada i de mitjana edat, i una elevada proporció presentaven factors predisposants, destacant l'alteració de la barrera cutània, la infecció per HIV, l'ús de drogues per via parenteral, i les neoplàsies. En la col·lecció de 126 soques analitzada es van identificar un total de 29 tipus emm amb una distribució encapçalada pel tipus emm1 (17,5%), seguit d'emm3 (8,7%), emm4 (8,7%), emm12 (7,1%), emm28 (7,1%), emm11 (6,3%) i emm77 (6,3%). Aquests set tipus van constituir el 61,9% del total de soques. No es van observar diferències significatives en la distribució de tipus emm entre soques aïllades d'infeccions invasives i no invasives amb l'única excepció del tipus poc freqüent emm25 que es va trobar associat a infeccions invasives en addictes a drogues per via parenteral. Es va trobar una forta correlació entre el patró de SAgs i el tipus emm independentment del tipus d'infecció. La resistència a eritromicina va mostrar un increment anual progressiu del 16,6% (1999) al 38,8% (2003) i va estar causada per soques pertanyents a 11 tipus emm. Les soques mef(A) positives dels tipus emm4, emm12 i emm75 i erm(B) positives dels tipus emm11 i emm25 constituïren el 80% de les soques resistents. La freqüència de resistència a tetraciclina va fluctuar durant el període estudiat (màxim 34,6% el 2002 i mínim 15,8% el 2001) i va ser superior en les soques resistents a eritromicina que en les soques sensibles (42,8% vs 18,7%). En les soques resistents a tetraciclina el gen tet(M) va ser el predominant i es va trobar en soques pertanyents a 14 tipus emm, mentre que el gen tet(O) només es va trobar en soques emm77. No es van observar diferències significatives en la prevalença de resistència a eritromicina ni a tetraciclina en el grup invasiu respecte del no invasiu. La prevalença de resistència a levofloxacino fou del 3,2%, incloent quatre soques amb sensibilitat reduïda o resistència intermèdia (CIM 2-4 µg/ml) i dues soques amb resistència d'alt nivell (CIM >32 µg/ml). La resistència de baix nivell es va associar a substitucions únicament en ParC (Ser80Pro, Ser79Ala, Ser79Phe i Ala121Val), mentre que la resistència d'alt nivell es va relacionar amb mutacions en ParC (Ser79Phe i Ala121Val) i GyrA (Ser81Tyr). / Streptococcus pyogenes (GAS) is a human pathogen responsible for a wide array of infections, ranging from pharyngitis and impetigo to severe invasive infections such as necrotizing fasciitis (NF) and streptococcal toxic shock syndrome (STSS). The resurgence and persistence of severe forms of GAS diseases reported since the mid 1980s have motivated intensive research on epidemiological, microbiological and clinical aspects of these diseases. A retrospective hospital-based study was conducted including 126 GAS isolates (27 from invasive infections and 99 from non-invasive infections) collected from January 1999 to June 2003. GAS isolates were characterized by emm type and subtype and superantigen (SAg) gene profile (speA-C, speF-J, speL, speM, ssa and smeZ). The prevalence and mechanisms of macrolide, tetracycline and levofloxacin resistance were also determined. The most common clinical presentations of invasive cases were skin and soft-tissue infections (40.7%). SSTS occurred in four cases (14.8%) and was associated to NF in half of the cases. Most invasive cases were found in adults, in particular among the elderly and the middle-aged, and a large proportion had underlying conditions, the most frequent being skin lesions, HIV infection, injection drug use, and malignancy. A total of 29 emm types were identified among the 126 isolates; the most prevalent were emm1 (17.5 %), followed by emm3 (8.7 %), emm4 (8.7 %), emm12 (7.1 %), emm28 (7.1 %), emm11 (6.3 %) and emm77 (6.3 %). These seven emm types accounted for 61.9 % of isolates. There were no differences in the emm type distribution between invasive and non-invasive infections, except for emm25 isolates, which were associated with invasive infections in injecting drug users. The SAg gene profiles were closely associated with the emm type and were independent of the disease type. The prevalence of erythromycin resistance showed an annual progressive increase from 16.6% (1999) to 38.8% (2003) and was caused by isolates belonging to 11 emm types. mef(A)-positive emm types 4, 12 and 75, and erm(B)-positive emm types 11 and 25 were responsible for up to 80% of the erythromycin-resistant isolates. The prevalence of tetracycline resistance fluctuated over the period studied (maximum 34.6% in 2002 and minimum 15.8% in 2001) and was higher in erythromycin-resistant isolates than in susceptible isolates (42.8% vs 18.7%). Among the tetracycline-resistant isolates, the tet(M) determinant was the most prevalent and was distributed in isolates belonging to 14 emm types, whereas tet(O) was only found in emm77 isolates. No significant differences in resistance rates to erythromycin or tetracycline were found between invasive and non-invasive isolates. The rate of resistance to levofloxacin was 3.2%, encompassing four isolates with reduced susceptibility or intermediate resistance (MIC 2-4 µg/ml) and two isolates with a high level of resistance (MIC >32 µg/ml). Low-level resistance was associated with alterations in ParC (Ser80Pro, Ser79Ala, Ser79Phe and Ala121Val), while high-level resistance was associated with alterations involving both ParC (Ser79Phe and Ala121Val) and GyrA (Ser81Tyr).
|
29 |
Charakterisierung von Streptococcus-pyogenes-Isolation von "invasiven" Infektionen aus Deutschland, 1996 - 2002: mikrobiologische Eigenschaften und Beziehungen zu klinischen Daten der PatientenWahl, Renate Ursula January 2008 (has links)
Zugl.: Aachen, Techn. Hochsch., Diss., 2008
|
30 |
THE ROLE OF RNases AND TEMPERATURE IN CAPSULE PRODUCTION AND REGULATION IN Streptococcus pyogenesSvencionis, Juan Pablo 01 December 2014 (has links)
Group A Streptococcus (GAS) is responsible for mild and common infections like tonsillitis and pharyngitis, and more serious invasive disorders like necrotizing fasciitis and glomerulonephritis. The ability to invade tissues is closely linked to the virulence factors expressed by the bacterium. Hyaluronic acid capsule expression is variable among all the strains in S. pyogenes and confers the capacity to evade the immune response. In a previous study, it was found that capsule production in CovR mutants was temperature-regulated, showing a basal level of capsule production at 37℃ but increased production was observed at 25℃. Moreover, it was found that when CvfA, an endoribonuclease, is mutated, this thermoregulation is abolished. Since an antisense RNA was found spanning the entire capsule operon, another ribonuclease, RNaseIII which is involved in dsRNA digestion, was considered as a possible candidate to regulate the antisense and capsule transcripts. In this study, the objective is to find if and how the ribonucleases regulate the capsule transcript and antisense RNA. Data suggests that RNaseIII does not have a role in the regulation. On the other hand, CvfA showed a key role in regulating transcript levels. Furthermore, temperature appears to have some effect on its activity.
|
Page generated in 0.0521 seconds